34th European Congress of Clinical Microbiology & Infectious Diseases

Tiziana Lazzarotto
Dr. Tiziana Lazzarotto will highlight the importance of testing for active CMV infection during early pregnancy. Attendees will learn more about the impact an undiagnosed infection can have on the baby, how to treat and prevent such infections, shine a light on the latest guidelines and associated changes, as well will help understand how molecular and serology testing synergize each other to provide the best testing algorithm and help reduce patient burden.

NgeeKeong Tan
At South West London Pathology, Ngee Keong Tan has been exploring using the high throughput cobas CMV viral load test in identifying congenital CMV infections. The sample types best for this testing, such as urine, saliva and vaginal secretions, are more atypical than standard plasma, and he will briefly present the goals, challenges and outcome of recently published data that highlights defining the technical procedures and medical implications.

Marc Lütgehetmann
EBV (Epstein-Barr Virus) DNAemia monitoring protocols are driven by patient risk factors and results allow for clinical adjustments in immunosuppression, potentially lowering the risk of PTLD. While plasma is more specific for prediction of disease, whole blood is an acceptable sample type in instances of maximizing sensitivity for early detection. Dr. Luetgehetmann will share his experience validating whole blood on the cobas x800 systems to broaden the sample type options within their laboratory.